Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of British Columbia

$25,000.00

Development of an imaging probe of BPS-001 to study the in vivo biodistribution of this complex biological drug candidate for prostate cancer therapy

FY 2016-17

Summary
Leeches have been known to excrete different active salivary proteins and peptides for a long time which forexample prevent blood clot formation. New research shows that some of these compounds show alsoanticancer activity. The company Biopep Solutions Inc. has extracted a multivalent complex of salivarypeptides, BPS-001, from leeches and found them to be active against prostate cancer cells. The exactmechanism of action is unknown but thought to be mediated through multiple pathways involvinganti-oxidation, anti-thrombin and immunological effects. One method of further exploring the activity ofBPS-001 and its mechanism of action is to radiolabel its active ingredients and then observe theirbiodistribution in vivo.For this project, Biopep Solutions will provide a standardized and purified multivalent peptide complex. Wewill then investigate a reproducible method of radiolabeling the components of the complex and analyze thepresence of labeled components using a HPLC/radiometric assay. Dr. Hafeli's group will then label thecomplex of peptides of BPS-001 with the radioisotope 67Ga. The radiolabeled complex will be subcutaneouslyinjected into two groups of mice, one of them normal mice, the other a model of prostate cancer (TRAMP-C2)followed by Single Photon Emission Computed Tomography (SPECT) imaging. With this method it is possibleto examine the compound's biodistribution pattern and kinetics in these mice over a 24 h time period and topotentially optimize or find new drug delivery avenues.
Program
Engage Grants Program
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
493305-2016
Name nom
Hafeli, Urs
Department département
Pharmaceutical Sciences, Faculty of
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
1
Nb partie
1
Application title
Development of an imaging probe of BPS-001 to study the in vivo biodistribution of this complex biological drug candidate for prostate cancer therapy
Keyword
NSERC
Application summary
Leeches have been known to excrete different active salivary proteins and peptides for a long time which forexample prevent blood clot formation. New research shows that some of these compounds show alsoanticancer activity. The company Biopep Solutions Inc. has extracted a multivalent complex of salivarypeptides, BPS-001, from leeches and found them to be active against prostate cancer cells. The exactmechanism of action is unknown but thought to be mediated through multiple pathways involvinganti-oxidation, anti-thrombin and immunological effects. One method of further exploring the activity ofBPS-001 and its mechanism of action is to radiolabel its active ingredients and then observe theirbiodistribution in vivo.For this project, Biopep Solutions will provide a standardized and purified multivalent peptide complex. Wewill then investigate a reproducible method of radiolabeling the components of the complex and analyze thepresence of labeled components using a HPLC/radiometric assay. Dr. Hafeli's group will then label thecomplex of peptides of BPS-001 with the radioisotope 67Ga. The radiolabeled complex will be subcutaneouslyinjected into two groups of mice, one of them normal mice, the other a model of prostate cancer (TRAMP-C2)followed by Single Photon Emission Computed Tomography (SPECT) imaging. With this method it is possibleto examine the compound's biodistribution pattern and kinetics in these mice over a 24 h time period and topotentially optimize or find new drug delivery avenues.